Tesamorelin for Sleep: What the Evidence Shows
What human and animal studies show about Tesamorelin for sleep, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Human RCT
- Human studies
- 1
- PubMed records, our ledger
- Animal studies
- 0
- PubMed records, our ledger
- Studies we summarised
- 1
- with an outcome for sleep
Evidence for sleep
Each row is an outcome related to sleep from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Body composition, fatigue, sleep and function | Low-dose tesamorelin did not significantly change body composition, fatigue, sleep, physical performance, glucose tolerance or cognition. | Human controlled trialn = 22 | eNeurologicalSci 2026, PMID 42382101 |
PubMed records for Tesamorelin and sleep: 1 human, 0 animal (search counts, not studies we reviewed). Grades follow our evidence scale.
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Other peptides people research for sleep
All peptides for sleep, comparedCommon questions
Does Tesamorelin help with sleep?
The strongest study we summarise for sleep is human rct evidence, across 1 study with an outcome for sleep. A trial result is not an approval; see the legal status.
Is Tesamorelin approved for sleep?
Tesamorelin is FDA approved (Egrifta). Which conditions that approval covers is set by the label; use for anything else is off-label.
What is the best peptide for sleep?
There is no single answer. Our sleep overview compares each candidate by evidence grade and legal status rather than by popularity.
More on Tesamorelin
Sources
- 1The effect of growth hormone-releasing hormone on cognition and brain connectivity in adults with cognition ranging from normal to mild cognitive impairment.eNeurologicalSci · 2026PMID 42382101Accessed 2 Oct 2026
Found an error? Report a correction.